90 related articles for article (PubMed ID: 2657866)
41. Functional and ligand binding studies suggest heterogeneity of platelet prostacyclin receptors.
Armstrong RA; Lawrence RA; Jones RL; Wilson NH; Collier A
Br J Pharmacol; 1989 Jul; 97(3):657-68. PubMed ID: 2474350
[TBL] [Abstract][Full Text] [Related]
42. Pharmacokinetics of the stable prostacyclin analogue, nileprost, in the rat.
Krause W; Schulze PE; Totzek M
Prostaglandins Leukot Med; 1983 Jul; 11(3):241-57. PubMed ID: 6351102
[TBL] [Abstract][Full Text] [Related]
43. [The pharmacokinetics of Oral-Turinabol in humans].
Schumann W
Pharmazie; 1991 Sep; 46(9):650-4. PubMed ID: 1798729
[TBL] [Abstract][Full Text] [Related]
44. Mass balance, metabolic disposition, and pharmacokinetics of a single oral dose of regorafenib in healthy human subjects.
Gerisch M; Hafner FT; Lang D; Radtke M; Diefenbach K; Cleton A; Lettieri J
Cancer Chemother Pharmacol; 2018 Jan; 81(1):195-206. PubMed ID: 29188322
[TBL] [Abstract][Full Text] [Related]
45. Zatebradine: pharmacokinetics of a novel heart-rate-lowering agent after intravenous infusion and oral administration to healthy subjects.
Roth W; Bauer E; Heinzel G; Cornelissen PJ; van Tol RG; Jonkman JH; Zuiderwijk PB
J Pharm Sci; 1993 Jan; 82(1):99-106. PubMed ID: 8429501
[TBL] [Abstract][Full Text] [Related]
46. Pharmacokinetics of treprostinil sodium administered by 28-day chronic continuous subcutaneous infusion.
Wade M; Baker FJ; Roscigno R; DellaMaestra W; Arneson CP; Hunt TL; Lai AA
J Clin Pharmacol; 2004 May; 44(5):503-9. PubMed ID: 15102871
[TBL] [Abstract][Full Text] [Related]
47. Pharmacokinetics of dexloxiglumide after administration of single and repeat oral escalating doses in healthy young males.
Persiani S; D'Amato M; Makovec F; Tavares IA; Bishai PM; Rovati LC
Int J Clin Pharmacol Ther; 2002 May; 40(5):198-206. PubMed ID: 12051571
[TBL] [Abstract][Full Text] [Related]
48. The pharmacological effects of cicaprost, an oral prostacyclin analogue, in patients with Raynaud's syndrome secondary to systemic sclerosis--a preliminary study.
Lau CS; McLaren M; Saniabadi A; Scott N; Belch JJ
Clin Exp Rheumatol; 1991; 9(3):271-3. PubMed ID: 1879086
[TBL] [Abstract][Full Text] [Related]
49. Disposition and metabolism of radiolabeled casopitant in humans.
Pellegatti M; Bordini E; Fizzotti P; Roberts A; Johnson BM
Drug Metab Dispos; 2009 Aug; 37(8):1635-45. PubMed ID: 19420128
[TBL] [Abstract][Full Text] [Related]
50. A double-tracer technique to characterize absorption, distribution, metabolism and excretion (ADME) of [
Guerini E; Schadt S; Greig G; Haas R; Husser C; Zell M; Funk C; Hartung T; Gloge A; Mallalieu NL
Xenobiotica; 2017 Feb; 47(2):144-153. PubMed ID: 27123695
[TBL] [Abstract][Full Text] [Related]
51. Pharmacokinetics and biotransformation of the prostacyclin analogue, ZK 36 374. III. Development of a radioimmunoassay and its application to the pharmacokinetics of ZK 36 374 in the rat.
Krause W; Nieuweboer B
Prostaglandins Leukot Med; 1983 Mar; 10(3):289-99. PubMed ID: 6189134
[TBL] [Abstract][Full Text] [Related]
52. Pharmacokinetics of the citrus flavanone aglycones hesperetin and naringenin after single oral administration in human subjects.
Kanaze FI; Bounartzi MI; Georgarakis M; Niopas I
Eur J Clin Nutr; 2007 Apr; 61(4):472-7. PubMed ID: 17047689
[TBL] [Abstract][Full Text] [Related]
53. Pharmacokinetics and steady-state bioequivalence of treprostinil sodium (Remodulin) administered by the intravenous and subcutaneous route to normal volunteers.
Laliberte K; Arneson C; Jeffs R; Hunt T; Wade M
J Cardiovasc Pharmacol; 2004 Aug; 44(2):209-14. PubMed ID: 15243302
[TBL] [Abstract][Full Text] [Related]
54. Pharmacokinetics of intravenous and oral enoxacin in healthy volunteers.
Chang T; Black A; Dunky A; Wolf R; Sedman A; Latts J; Welling PG
J Antimicrob Chemother; 1988 Feb; 21 Suppl B():49-56. PubMed ID: 3162901
[TBL] [Abstract][Full Text] [Related]
55. Pharmacokinetics and metabolic pattern after intravenous infusion and oral administration to healthy subjects.
Schmid J; Busch U; Heinzel G; Bozler G; Kaschke S; Kummer M
Drug Metab Dispos; 1995 Nov; 23(11):1206-13. PubMed ID: 8591720
[TBL] [Abstract][Full Text] [Related]
56. Pharmacokinetics of 14C-radioactivity after oral intake of a single dose of 14C-labeled fampridine (4-aminopyridine) in healthy volunteers.
Blight AR; Henney HR
Clin Ther; 2009 Feb; 31(2):328-35. PubMed ID: 19302905
[TBL] [Abstract][Full Text] [Related]
57. Pharmacokinetics of loxiglumide after single intravenous or oral doses in man.
Setnikar I; Chisté R; Makovec F; Rovati LC; Warrington SJ
Arzneimittelforschung; 1988 May; 38(5):716-20. PubMed ID: 3415715
[TBL] [Abstract][Full Text] [Related]
58. Orally active inhibitors of human leukocyte elastase. I. Disposition of L-683,845 in rats and rhesus monkeys.
Vincent SH; Painter SK; Krieter PA; Colletti AE; Lyszack E; Rosegay A; Dean D; Luffer-Atlas D; Miller RR; Cioffe C; Chiu SH
Drug Metab Dispos; 1996 Dec; 24(12):1369-77. PubMed ID: 8971144
[TBL] [Abstract][Full Text] [Related]
59. Tumor metastasis inhibition with the prostacyclin analogue cicaprost depends on discontinuous plasma peak levels.
Schirner M; Kraus C; Lichtner RB; Schneider MR; Hildebrand M
Prostaglandins Leukot Essent Fatty Acids; 1998 Apr; 58(4):311-7. PubMed ID: 9654405
[TBL] [Abstract][Full Text] [Related]
60. Pharmacokinetics, metabolism, and excretion of the antidiabetic agent ertugliflozin (PF-04971729) in healthy male subjects.
Miao Z; Nucci G; Amin N; Sharma R; Mascitti V; Tugnait M; Vaz AD; Callegari E; Kalgutkar AS
Drug Metab Dispos; 2013 Feb; 41(2):445-56. PubMed ID: 23169609
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
